Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

Delayed Quote. Delayed Nyse - 04/17 04:00:29 pm
38.93 USD   +1.43%
19h agoDJIndia's Piramal Enterprises Buys Stake in Local Financier
1d ago ABBOTT LABORATORIES : Recall hurts Abbott, but still tops expectations
1d agoDJU.S. HOT STOCKS : Hot Stocks to Watch
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Abbott Laboratories : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84822 54023 79425 112
Operating income (EBITDA)11 21612 6164 9745 4706 0296 645
Operating profit (EBIT)9 0109 8334 0464 1424 6254 942
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 8683 1723 556
EPS ( $)3,013,721,621,752,012,31
Dividend per Share ( $)1,881,67-0,840,961,07
Yield4,90%4,35%-2,18%2,51%2,79%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Abbott Laboratories : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 674-2 04796,1-
Finance-----508
Operating income (EBITDA)11 21612 6164 9745 4706 0296 645
Leverage
(Debt/EBITDA)
0,77x0,77x-0,37x0,02x-
Capital Expenditure1 4921 795-1 2011 2251 278
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,3 $17,2 $18,7 $
Cash Flow per Share5,72 $5,85 $-2,79 $2,96 $3,35 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Abbott Laboratories : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 59 223 M$ -
Company Value 61 270 M$ 59 319 M$
Valuation 2014e 2015e
PER (Price / EPS) 22,0x 19,1x
Capitalization / Revenue 2,63x 2,49x
EV / Revenue 2,72x 2,49x
EV / EBITDA 11,2x 9,84x
Yield (DPS / Price) 2,18% 2,51%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,4% 19,4%
operating Leverage (Delta EBIT / Delta Sales) 0,75x 2,10x
Net Margin (Net Profit / Revenue) 12,7% 13,3%
ROA (Net Profit / Asset) 7,36% 7,74%
ROE (Net Profit / Equities) 13,2% 13,7%
Rate of Dividend 47,8% 48,0%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   5,33% 5,15%
Cash Flow / Sales (Taux d'autofinancement) 19,1% 19,2%
Capital Intensity (Assets / Sales) 1,73x 1,72x
Financial Leverage (Net Debt / EBITDA) 0,37x 0,02x
Price Earning Ratio
Abbott Laboratories : Price Earning Ratio
EPS & Dividend
Abbott Laboratories : EPS Dividend
Dynamic quotes  
ON
| OFF